AzTrials
AzTrials

Low Back PainNCT03475095

Motor Control Mechanisms by CNS of Tuina in Patients With Lumbar Disk Herniation

A study testing Tuina in people with Low Back Pain and Disc, Herniated, run by The First Affiliated Hospital of Zhejiang Chinese Medical University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Lumbar disk herniation (LDH)is a prevalent health problem around the world. It can cause symptoms of low back pain, numbness or weakness.The understanding of low back pain in traditional Chinese medicine(TCM) theory"unbalanced bones and muscles"that is consistent with the description of modern medicine on LDH function… Read more about this study

Who is it for?
Ages 25 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Low Back Pain, Disc, Herniated
What is being tested?
Tuina
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteChina
Study dates
10 Mar 2018to 31 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • accord with the diagnostic criteria of lumbar disc herniation in the seventh edition of "Surgery", and diagnosed by MRI, the course of acute patients ≤ 1 month, the course of chronic patients ≥ 3 months
  • Age:25~40 years old
  • VAS score ≥30/100
  • Waist ODI index≥20%
  • Self-rating anxiety scale (SAS)<59 points, Self-rating Depression Scale (SDS) <53 points
  • BMI<24
  • Signed the Informed Consent Form

Who cannot join

  • History of spinal surgery or history of severe spine trauma
  • Combined with other lumbar conditions may interfere with clinical outcomes (e.g. bone tuberculosis, tumors and severe osteoporosis)
  • Combines cardiovascular disease, blood system, digestive system and other serious medical diseases or psychosis
  • Women at childbearing age and of pregnancy desire during the study
  • combined with autoimmune diseases, allergy Sexual diseases, acute and chronic infectious diseases
  • Presence of any major physical or neurological illness
Show all 9Show fewer
  • MRI contraindication
  • MRI showed nucleus pulposus free, cauda equina syndrome
  • vision loss, vestibular dysfunction

Trial locations and contacts

1 site in 1 country.

honggen Du, master contact

+86-0571-87070217

duhonggen1212@163.com

keding Shao, master contact

+86-0571-86613536

knail@163.com

China1 site, 1 recruiting
  • The First Affiliated Hospital of Zhejiang Chinese Medical University

    Hangzhou, Zhejiang, 310006

    honggen Du, MD, +86-057187070217, duhonggen1212@163.com

    Recruiting

Other trials in China

About this study

Official title: A Mechanism of Tuina Treating Lumbar Disc Herniation Based of Central Nervous System Motion Control Modulating Reconstruction of Lumbar Stabilizer Function

Lumbar disk herniation (LDH)is a prevalent health problem around the world. It can cause symptoms of low back pain, numbness or weakness.The understanding of low back pain in traditional Chinese medicine(TCM) theory"unbalanced bones and muscles"that is consistent with the description of modern medicine on LDH function pathology. Tuina is one of Diagnosis and treatment methods in TCM which has been used as a noninvasive treatment of LDH. However, the mechanism of Tuina therapy in LDH is still unclear.The purpose of this study is to establish a platform of the therapeutic effect and mechanical effect of LDH in the treatment of LDH,explore the characteristics of Tuina by the motor control in lumbar CNS,observe the patterns and regularities in the function of related brain regionin of patients with acute or chronic LDH and reveal the mechanism of Tuina of improving the control of lumbar spine CNS movement.

Read the detailed description

Clinical researches has demonstrated the effectiveness of Tuina on lumbar disc herniation (LDH), but the mechanism remains unclear.The existing researches mainly focus on the mechanical mechanism of the local stability reconstruction of the lumbar spine. Our previous study found that LDH patients have lumbar CNS motion control disorder, and preliminary studies have shown that Tuina can improve the lumbar CNS motion control efficiency, also fMRI studies found that abnormal motion related brain areas had an active trend during the acute phase and a suppressed trend in the chronic period.Therefore,we hypothesize that Tuina could improve the lumbar CNS motion control in LDH patients, and could response to the effect of local mechanical lumbar as well as bidirectionally regulate the function of lumbar stabilizers, which facilitates the stable reconstruction of lumbar. This project will illuminate the effect of Tuina improving the lumbar CNS motion control by applying the latest fMRI, surface electromyography and data mining technology to the acute and chronic LDH patients with a combination of efficacy and experimental verification to reveal the mechanism of CNS bidirectional regulation of paraspinal muscle activity by the response of related brain regions to mechanical effects after Tuina on the lumbar. This project provides a new thinking to the research of the therapeutic mechanism of LDH, which is a scientific significance.

Being tested
Tuina
Keywords
Low Back Pain, Tuina therapy, lumbar disc herniation, central motion control, functional magnetic resonanceimaging, effect mechanism, Chronic nonspecific low Back pain
Medical subject headings
Low Back Pain, Intervertebral Disc Displacement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TuinaOther

    Patients will receive Tuina therapies tiwce per week in one month.each time lasts about 20 minutes,a total of 4 weeks.

Study groups in NCT03475095
Study groupRoleWhat they receive
LDH patientsExperimental"ribs and bones" Tuina therapy According to the diagnostic criteria of"vertebral dislocation",determine the position,degree and direction of the dislocation,assess the activity of the affected vertebrae.Treated with combining Tuina of muscle-loosing and bone-setting such as reinforcing ribs,kneading and plucking method,20 min every treatment,twice a week for a total time of 4 weeks.
Receives: Other: Tuina

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual analogue scale (VAS)

    Assessment of pain intensity before treatment of all patients,collate related data and statistically analyzed.

    Measured: 6 weeks

  2. Oswestry Disability Index (ODI)

    Assessment of symptoms and severity of low back pain

    Measured: 6 weeks

  3. Biering-Sørensen test

    Assessment of endurance of the lumbar paraspinal muscle

    Measured: 6 weeks

  4. Rapid reaction time

    Measurement of rapid reaction time will be conducted in surface electromyo gram

    Measured: 6 weeks

Secondary outcomes (7)
  1. Finite element analysis

    Intervertebral disc biomechanical analysis

    Measured: 12 weeks

  2. Resting state functional magnetic resonance imaging and magnetic resonance spectroscopy

    Identification of brain activation in the motor area during Tuina.

    Measured: 12 weeks

  3. Visual analogue scale (VAS)

    Assessment of pain intensity before treatment of all patients,collate related

    Measured: 12 weeks

  4. Oswestry Disability Index (ODI)

    Assessment of symptoms and severity of low back pain

    Measured: 12 weeks

  5. Biering-Sørensen test

    Assessment of endurance of the lumbar paraspinal muscle

    Measured: 12 weeks

  6. Cross sectional area of multifidus

    Measurement of Cross Sectional Area of Multifidus will be performed on MR images

    Measured: 12 weeks

  7. Rapid reaction time

    Measurement of rapid reaction time will be conducted in surface electromyo gram

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Mar 2018
  2. Study start10 Mar 2018
  3. Primary completion31 May 2019 (estimated)
  4. Study completion31 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03475095
Sponsor's protocol ID
LDH-001
Status last verified
Mar 2018
First submitted
12 Mar 2018
Last updated
23 Mar 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Tsuji T, Matsuyama Y, Sato K, Hasegawa Y, Yimin Y, Iwata H. Epidemiology of low back pain in the elderly: correlation with lumbar lordosis. J Orthop Sci. 2001;6(4):307-11. doi: 10.1007/s007760100023.

    PubMed 11479757

Questions about this trial

What is this clinical trial studying?

A study testing Tuina in people with Low Back Pain and Disc, Herniated, run by The First Affiliated Hospital of Zhejiang Chinese Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Mar 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact honggen Du, master (+86-0571-87070217, duhonggen1212@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual analogue scale (VAS) (time frame: 6 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03475095, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Mar 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in